Sofinnova BioEquities Enhanced Offshore Fund Ltd. — Form D/A
Sofinnova BioEquities Enhanced Offshore Fund Ltd. of GRAND CAYMAN, E9, a pooled investment fund, filed a Form D amendment with the SEC on 2025-10-10. $226.3M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-10-10
- Form: D/A
- Accession: 0000919574-25-006043
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $226.3M
- Minimum investment: $100K
- Investors: 2
- Date of first sale: 2022-10-01
- Security types: equity, fund interests
- SEC file number: 021-461677
Issuer
- Name: Sofinnova BioEquities Enhanced Offshore Fund Ltd.
- CIK: 0001949442
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2022
- Address: 94 SOLARIS AVENUE, CAMANA BAY, GRAND CAYMAN, E9, KY1-1108
- Phone: 650-681-8482
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Eric Delbridge | Director | Menlo Park, CA |
| Cary Marr | Director | George Town, Grand Cayman, E9 |
| Paul Stevenson | Director | Hamilton, D0 |
| -- Sofinnova Investments, Inc. | Executive Officer | Menlo Park, CA |
| -- Sofinnova Investments, Inc. | Promoter | Menlo Park, CA |
Other filings by this issuer (3)
More